Patent · US Active

Pyridine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof

US9452995B2 · kind B2 · utility

1Cited by
3References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 22, 2015
Grant dateSep 27, 2016
Priority date
Expiry dateJun 22, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

PIM kinase inhibitor compound having a structure as represented by Formula I, and isomers, diastereomers, enantiomers, tautomers, and pharmaceutically acceptable salts thereof. The compounds significantly inhibit the Pim kinase activity and are used to prepare drugs to treat PIM kinase mediated diseases, such as cancers, multi drug resistance, and inflammatory bowel disease. Also provided are methods for preparing and using the compounds represented by Formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.